ATE184483T1 - Spirooxathiolan-quinuclidin-derivat zur behandlung des sjögren-syndroms - Google Patents

Spirooxathiolan-quinuclidin-derivat zur behandlung des sjögren-syndroms

Info

Publication number
ATE184483T1
ATE184483T1 AT93305423T AT93305423T ATE184483T1 AT E184483 T1 ATE184483 T1 AT E184483T1 AT 93305423 T AT93305423 T AT 93305423T AT 93305423 T AT93305423 T AT 93305423T AT E184483 T1 ATE184483 T1 AT E184483T1
Authority
AT
Austria
Prior art keywords
spirooxathiolane
quinuclidine
sjögren
syndrome
treatment
Prior art date
Application number
AT93305423T
Other languages
English (en)
Inventor
Nobuaki Abe
Yasuyoshi Takeshita
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16540522&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE184483(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Application granted granted Critical
Publication of ATE184483T1 publication Critical patent/ATE184483T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AT93305423T 1992-07-10 1993-07-09 Spirooxathiolan-quinuclidin-derivat zur behandlung des sjögren-syndroms ATE184483T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4207485A JP2683783B2 (ja) 1992-07-10 1992-07-10 シェーグレン症候群治療剤

Publications (1)

Publication Number Publication Date
ATE184483T1 true ATE184483T1 (de) 1999-10-15

Family

ID=16540522

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93305423T ATE184483T1 (de) 1992-07-10 1993-07-09 Spirooxathiolan-quinuclidin-derivat zur behandlung des sjögren-syndroms

Country Status (15)

Country Link
US (1) US5340821A (de)
EP (1) EP0578511B1 (de)
JP (1) JP2683783B2 (de)
KR (1) KR100331046B1 (de)
AT (1) ATE184483T1 (de)
AU (1) AU666734B2 (de)
CA (1) CA2099970C (de)
DE (1) DE69326395T2 (de)
DK (1) DK0578511T3 (de)
ES (1) ES2138613T3 (de)
IL (1) IL106218A (de)
NO (1) NO303765B1 (de)
NZ (1) NZ248099A (de)
TW (1) TW230750B (de)
ZA (1) ZA934883B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2852608B2 (ja) * 1994-06-27 1999-02-03 雪印乳業株式会社 口腔乾燥症治療剤
US6140374A (en) * 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
JP4447685B2 (ja) * 1999-01-14 2010-04-07 第一三共株式会社 皮膚乾燥症治療剤
US20110150974A1 (en) * 2004-08-06 2011-06-23 Daiichi Pharmaceutical Co., Ltd. Agent For Oral Mucosal Administration
JP2006070027A (ja) * 2004-08-06 2006-03-16 Dai Ichi Seiyaku Co Ltd 口腔粘膜投与剤
KR20070061578A (ko) * 2004-10-05 2007-06-13 아스텔라스세이야쿠 가부시키가이샤 눈물 및 침 건조증 치료용 의약 조성물
EP2258359A3 (de) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenese durch Modulation des Muscarinrezeptors mit Sabcomelin
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド ムスカリン性受容体調節による神経発生
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2026813A2 (de) 2006-05-09 2009-02-25 Braincells, Inc. 5-ht-rezeptor-vermittelte neurogenese
EP2377531A2 (de) 2006-05-09 2011-10-19 Braincells, Inc. Neurogenese mittels Angiotensin-Modulation
US7998971B2 (en) 2006-09-08 2011-08-16 Braincells Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US8143400B2 (en) * 2008-01-10 2012-03-27 Apotex Pharmachem Inc. Process for the preparation and purification of cis-2-methylspiro(1,3-oxathiolane-5,3′)quiniclidine hydrochloride
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2011058366A1 (en) 2009-11-12 2011-05-19 Acacia Pharma Limited Use of bethanechol for treatment of xerostomia
GB201107533D0 (en) 2011-05-06 2011-06-22 Acacia Pharma Ltd Formulaiton
CN102846607A (zh) * 2012-04-09 2013-01-02 珠海亿邦制药股份有限公司 一种以盐酸西维美林为活性成分的固体制剂及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001396A (en) * 1971-08-04 1977-01-04 Chinoin Pharmaceutical And Chemical Works Ltd. Hormonal product extracted from parathyroid gland and process for the preparation thereof
US4110441A (en) * 1974-04-29 1978-08-29 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. Gamma-l-glutamyl cholamine phosphate
US4100271A (en) * 1976-02-26 1978-07-11 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators
US4855290A (en) * 1985-05-10 1989-08-08 State Of Israel, Represented By Prime Minister's Office, Israel Institute For Biological Research Derivatives of quinuclidine
US4684727A (en) * 1985-07-29 1987-08-04 Schering Corporation Zwitterionic 1,8-naphthyridine and pyrazino[2,3-b]pyridine containing compounds useful as anti-allergic, anti-inflammatory and cycloprotective agents
ZA868369B (en) * 1986-01-10 1987-11-25 Israel State Derivatives of quinuclidine
GB8717446D0 (en) * 1987-07-23 1987-08-26 Merck Sharp & Dohme Chemical compounds
US4876260A (en) * 1987-10-28 1989-10-24 State Of Israel, Israel Institute Of Biological Research Oxathiolanes
CA1303503C (en) * 1987-11-10 1992-06-16 Marc Plamondon Ophthalmic solution comprising iodine-polyvinylpyrrolidone complex
WO1990005525A1 (en) * 1988-11-23 1990-05-31 Pfizer Inc. Quinuclidine derivatives as substance p antagonists
US4997654A (en) * 1989-08-14 1991-03-05 Warner-Lambert Company Method for increasing salivation for xerostomia patients
ATE154354T1 (de) * 1991-02-11 1997-06-15 Merck Sharp & Dohme Azabicyclische verbindungen, diese enthaltende pharmazeutische zubereitungen und ihre therapeutische verwendung

Also Published As

Publication number Publication date
KR940005274A (ko) 1994-03-21
EP0578511B1 (de) 1999-09-15
JP2683783B2 (ja) 1997-12-03
AU666734B2 (en) 1996-02-22
IL106218A (en) 1997-02-18
US5340821A (en) 1994-08-23
JPH0624981A (ja) 1994-02-01
EP0578511A1 (de) 1994-01-12
NO303765B1 (no) 1998-08-31
NO932520L (no) 1994-01-11
NZ248099A (en) 1999-07-29
AU4181993A (en) 1994-01-13
CA2099970A1 (en) 1994-01-11
DE69326395D1 (de) 1999-10-21
CA2099970C (en) 2003-12-30
DE69326395T2 (de) 2000-04-20
DK0578511T3 (da) 2000-04-03
NO932520D0 (no) 1993-07-09
KR100331046B1 (ko) 2002-08-19
IL106218A0 (en) 1993-11-15
TW230750B (de) 1994-09-21
ZA934883B (en) 1994-02-03
ES2138613T3 (es) 2000-01-16

Similar Documents

Publication Publication Date Title
ATE184483T1 (de) Spirooxathiolan-quinuclidin-derivat zur behandlung des sjögren-syndroms
ATE103812T1 (de) Zusammensetzung zur behandlung von ischaemischen stoerungen in organen.
DK0493608T3 (da) Quinoloncarboxylsyrederivat
HU9603433D0 (en) Novel 4-6-diaryl-pyrimidine-derivatives and salts thereof
ES2031569T3 (es) Derivados de acidos quinolinocarboxilicos.
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
DE69828197D1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
DE69123757D1 (de) Epoxysuccinamidsäurederivat
DE69411852D1 (de) Indolderivate, ihre Salze und sie enthaltende Arzneimittel zur Behandlung von Herzkrankheiten
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
ATE265212T1 (de) Verwendung von 4-acylaminopyridin derivaten zur herstellung eines medikaments für die behandlung von zerebrovaskulären erkrankungen
DE3884878T2 (de) Uricosuretische Zusammensetzung.
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
ATE103490T1 (de) Derivate der p-guanidinobenzoesaeure zur behandlung der zerebrovaskulaeren kontraktion.
DE69424677T2 (de) Präparat zur behandlung der drogenabhängigkeit

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner